Efficacy and safety of apatinib combined with liposomal doxorubicin or paclitaxel versus liposomal doxorubicin or paclitaxel monotherapy in patients with recurrent platinum‐resistant ovarian cancer
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Obstetrics and Gynaecology Research"
DOI: 10.1111/jog.15644
Abstract: Apatinib is an effective treatment for patients with gynecological cancers. This study aimed to further explore the efficacy and safety of apatinib plus chemotherapy in patients with recurrent platinum‐resistant ovarian cancer (PROC). read more here.
Keywords: efficacy safety; doxorubicin paclitaxel; safety apatinib; liposomal doxorubicin ... See more keywords
Propofol Inhibits Proliferation and Augments the Anti-Tumor Effect of Doxorubicin and Paclitaxel Partly Through Promoting Ferroptosis in Triple-Negative Breast Cancer Cells
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.837974
Abstract: Background Triple-negative breast cancer (TNBC) is relatively common in women and is associated with a poor prognosis after surgery and adjuvant chemotherapy. Currently, the mechanism underlying the relationship between propofol and breast cancer is controversial… read more here.
Keywords: propofol; doxorubicin paclitaxel; breast cancer; ferroptosis ... See more keywords